Other clinical trials in people with non-Hodgkin's lymphoma [24] and sufferers with Superior malignancy [fourteen] have shown also that zosuquidar didn't drastically have an effect on the pharmacokinetics of doxorubicin and experienced moderate results on the pharmacokinetics of vincristine. These scientific trials accepted that zosuquidar could properly administrated with daunorubicin, https://lefamulinacetate88654.blog2learn.com/76213192/fascination-about-gw7647